Publication:


abstract

alginate microbeads have been investigated clinically for a number of therapeutic interventions, including drug delivery for treatment of ischemic tissues, cell delivery for tissue regeneration, and islet encapsulation as a therapy for type I diabetes. The physical properties of the microbeads play an important role in regulating cell behavior, protein release, and biological response following implantation. In this research alginate microbeads were synthesized, varying composition (mannuronic acid to guluronic acid ratio), concentration of alginate and needle gauge size. Following synthesis, the size, volume fraction, and morphometry of the beads were quantified. In addition, these properties were monitored over time in vitro in the presence of varying calcium levels in the microenvironment. The initial volume available for solute diffusion increased with alginate concentration and mannuronic (M) acid content, and bead diameter decreased with M content but increased with needle diameter. Interestingly, microbeads eroded completely in saline in less than 3 weeks regardless of synthesis conditions much faster than what has been observed in vivo. However, microbead Stability was increased by the addition of calcium in the culture medium. Beads synthesized with low alginate concentration and high G content exhibited a more rapid change in physical properties even in the presence of calcium. These data suggest that temporal variations in the physical characteristics of alginate microbeads can occur in vitro depending on synthesis conditions and microbead environment. The results presented here will assist in optimizing the design of the materials for clinical application in drug delivery and cell therapy.

Related Articles
Effect of alginate composition and gelling cation on microbead swelling.
J Microencapsul. 2006
Effect of alginate composition and gelling cation on microbead swelling.
Darrabie MD, Kendall WF, Opara EC. J Microencapsul. 2006 Sep; 23(6):613-21.
Effect of alginate composition and purity on alginate microspheres.
J Microencapsul. 2004
Effect of alginate composition and purity on alginate microspheres.
Kendall WF Jr, Darrabie MD, El-Shewy HM, Opara EC. J Microencapsul. 2004 Dec; 21(8):821-8.
Protein release from alginate matrices.
Adv Drug Deliv Rev. 1998
Protein release from alginate matrices.
Wee S, Gombotz WR. Adv Drug Deliv Rev. 1998 May 4; 31(3):267-285.
Review Evaluation of chitosan/alginate beads using experimental design: formulation and in vitro characterization.
AAPS PharmSciTech. 2010
Review Evaluation of chitosan/alginate beads using experimental design: formulation and in vitro characterization.
Takka S, Gürel A. AAPS PharmSciTech. 2010 Mar; 11(1):460-6. Epub 2010 Mar 19.
Review Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
J Control Release. 2006
Review Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
George M, Abraham TE. J Control Release. 2006 Aug 10; 114(1):1-14. Epub 2006 May 22.